Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease and Related Dementias (R01)

This  grant invites applications that combine computational and experimental approaches to enable rigorous preclinical testing, in robust mouse models, of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in Alzheimer's Disease (AD) and AD-related dementias (ADRD). 

Funding: $1,000,000 per year

Duration: 5 years

Research Authority due date: 10 days prior to submission

LOI (encouraged) due date: 9.5.25, 6.9.25, 6.1.26, 9.5.26, 6.9.26, 8.1.27, 9.5.27, 8.9.27, 7.1.28

Full proposal due date: 9.6.25, 6.10.25, 6.2.26, 9.6.26, 6.10.26, 8.2.27, 9.6.27, 8.10.27, 7.2.28